Panel held to discuss possible cuts to Medicaid
(COLORADO SPRINGS) — Local health care workers and Democrats held a panel on Tuesday, June 10 discussing how Medicaid budget cuts could impact Colorado Springs.
Data shows 19% of the 5th Congressional District, which covers most of El Paso County, are enrolled in Medicaid. Organizers of the panel said that number could drop if President Donald Trump signs his so-called 'Big Beautiful Bill.'
The bill adds restrictions to who would be eligible for Medicaid, which Republicans argue would cut down on fraud. However, those at the panel on Tuesday disagree, arguing these cuts will impact services across the board. They said the only way to make sure your voice is heard is to speak up to the lawmakers who represent you.
'Call your representatives. There is somebody, they ain't going to answer the phone, but there is somebody who can answer the phone. Get out. Speak your mind. Talk to your neighbor. Find out what goes on,' said Leeann Webster with CA Home Health Care.
The senate is currently debating the controversial bill. Both Colorado Senators John Hickenlooper and Michael Bennett both indicated they will not vote in favor of the measure.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gizmodo
28 minutes ago
- Gizmodo
Bats Have Cancer-Fighting ‘Superpowers'—Here's What That Means for Humans
When you think of longevity in animals, chances are that the Greenland shark will immediately come up. After all, researchers estimate that the enigmatic animal can live for at least 250 years. It turns out, however, that bats also hold their own when it comes to lifespan, with some species living up to 25 years—equivalent to 180 human years—and they tend to do it cancer-free. Researchers from the University of Rochester (UR) have investigated anti-cancer 'superpowers,' as described in a UR statement, in four bat species: the little brown bat, the big brown bat, the cave nectar bat, and the Jamaican fruit bat. The results of their investigation could have important implications for treating cancer in humans. 'Longer lifespans with more cell divisions, and longer exposure to exo- [external] and endogenous [internal] stressors increase cancer incidence,' the researchers wrote in a study published last month in the journal Nature Communications. 'However, despite their exceptional lifespans, few to no tumors have been reported in long-lived wild and captive populations of bats.' Led by biologists Vera Gorbunova and Andrei Seluanov from the UR Department of Biology and Wilmot Cancer Institute, the team identified a number of biological defenses that help bats avoid the disease. For example, bats have a tumor-suppressor gene, called p53. Specifically, little brown bats carry two copies of the gene, and have high p53 activity, which can get rid of cancer cells during apoptosis, a biological process that eliminates unwanted cells. 'We hypothesize that some bat species have evolved enhanced p53 activity as an additional anti-cancer strategy, similar to elephants,' the researchers explained. Too much p53, though, runs the risk of killing too many cells. Clearly, bats are able to find the right apoptosis balance. Humans also have p53, but mutations in the gene—which disrupt its anti-cancer properties—exist in around 50% of human cancers. The researchers also analyzed the enzyme telomerase. In bats, the telomerase expression allows bat cells to multiply endlessly. That means they don't undergo replicative senescence: a feature that restricts cell proliferation to a certain number of divisions. Since, according to the study, senescence 'promotes age-related inflammation contributing to the aging process,' bats' lack thereof would seem to promote longevity. And while indefinite cell proliferation might sound like the perfect cancer hotbed, bats' high p53 activity can kill off any cancer cells. Furthermore, 'bats have unique immune systems which allows them to survive a wide range of deadly viruses, and many unique immune adaptations have been described in bats,' the researchers wrote. 'Most knowledge of the bat immune systems comes from studies of bat tolerance to viral infections deadly to humans. However, these or similar immune adaptations may also recognize and eliminate tumors,' as well as 'temper inflammation, which may have an anticancer effect.' Cells have to go through several steps, or 'oncogenic hits,' to become harmful cancerous cells. Surprisingly, the researchers also found that it only takes two hits for normal bat cells to become malignant, meaning bats aren't naturally resistant to cancer—they just have 'robust tumor-suppressor mechanisms,' as described in the statement. The team's findings carry important implications for treating cancer. Specifically, the study confirms that increased p53 activity—which is already targeted by some anti-cancer drugs—can eliminate or slow cancer growth. More broadly, their research is yet another example of scientists turning to nature for solutions to human challenges on all scales. Though the study focuses on bats, the ultimate aim is, always, finding a cure for cancer in humans.
Washington Post
30 minutes ago
- Washington Post
Trump booed and cheered at the Kennedy Center
Politics Trump booed and cheered at the Kennedy Center June 12, 2025 | 1:44 PM GMT President Donald Trump attended opening night of 'Les Misérables' at the Kennedy Center, a venue that he has long avoided but is now trying to embrace after ousting its leadership and installing his own loyalists.
CNN
31 minutes ago
- CNN
Trump's agenda faces a $22 billion test from markets
Standard, boring bond auctions are drawing the attention of investors around the globe. The Treasury Department on Thursday will sell $22 billion worth of 30-year government bonds, in what will serve as a gauge of investors' appetite for US debt. All eyes are on whether there is weak demand, particularly from foreign investors. The Treasury auction, which is a regularly scheduled event, has become a closely watched barometer for how Wall Street is feeling about the Trump administration's policy agenda. A poor auction could reignite jitters about America's debt burden, President Donald Trump's 'One Big, Beautiful Bill Act' and the ability for lawmakers to get the country's finances in order. If there is weak demand for 30-year bonds at Thursday's auction, that would push yields higher. Bond yields and prices have an inverse relationship. When there is strong demand for bonds, prices rise and yields fall. Vice versa, when there is weak demand for bonds, prices fall and yields rise. Higher yields would squeeze the government with higher borrowing costs. Treasury yields are also benchmark interest rates for the economy, and higher yields can mean higher borrowing costs for consumers on everyday items including auto loans and credit cards. Long-term US debt, which is usually considered the safe, risk-free corner of the market, has come under scrutiny as Trump's tax bill is set to add to the federal debt burden. 'The idea that the US fiscal position is unsustainable over the long run has been frequently noted for years, but it has taken the current set of circumstances to get market participants to begin pushing back,' John Canavan, lead US analyst at Oxford Economics, said in a Wednesday note. Yields on 30-year Treasury bonds have soared this year as investors have demanded more compensation for what is looking like a riskier long-term loan to the US government. These concerns were exacerbated in May after Moody's downgraded the US, stripping the nation of its last perfect credit rating. 'The Moody's downgrade occurred as the ability to easily finance growing deficits increasingly comes into question,' Canavan said. 'Trump's tariff decisions are likely to raise inflation over the near term, while lowering economic growth and leading foreign investors to question the safe-haven allure of Treasury debt.' This is the first 30-year Treasury auction since Wall Street has begun focusing on the details of Trump's mega bill and the deficit, making it an important gauge of sentiment, Collin Martin, a fixed income strategist at Charles Schwab, told CNN. 'There's a concern that yields might need to rise to attract more and more investors to keep buying,' Martin said. 'If it's a weak auction, we'll probably see yields rise relatively sharply, because that might spook investors,' Martin added, 'and on the flip side, if it ends up being a pretty good auction, that would probably allow the markets to kind of breathe a sigh of relief that, okay, there is enough demand.' There is robust demand for shorter-term Treasuries like 10-year bonds, according to Chip Hughey, managing director for fixed income at Truist Advisory Services. An auction for 10-year Treasuries on Wednesday saw strong demand both for domestic and global investors. Yet investors have shown hesitancy about longer-duration bonds like the 30-year bond, Hughey said. Investors are increasingly uncertain about the long-term outlook for the US debt burden, giving them pause about the risk associated with loaning money to the government over a longer period. 'There certainly is a little bit of hesitancy about taking on a great deal of duration, just given the uncertainty around trade policy and deficits, and also what that would mean for your future debt supply,' Hughey said. 'The 30-year reflects the uncertainties around those more structural questions around budget deficits and the US debt load going forward.' In May, the 30-year yield spiked to its highest level since 2023 after a Treasury auction for 20-year bonds that saw weak demand. Pacific Investment Management Company, a global fixed income firm, said in a Tuesday report that bonds still look relatively attractive and affordable compared to stocks. However, Pimco expects to focus and be 'overweight' to 5- and 10-year bonds, while being less focused and 'underweight' to longer-term bonds. Martin at Charles Schwab said that while concerns about the deficit linger, investors are also assessing factors like inflation and the path of potential Federal Reserve rate cuts. The latest data showed that consumer prices cooled more than expected in May. Fixed income assets like bonds can become more appealing when inflation is cooling. 'We still find yields pretty attractive, and our outlook on the safety of US Treasuries hasn't changed,' Martin said. Elsewhere in markets, US stocks opened lower on Thursday. The Dow was lower by 250 points, or 0.6%. The broader S&P 500 fell 0.3% and the tech-heavy Nasdaq Composite slid 0.25%. The S&P 500 is hovering near an all-time high, but has stalled in recent trading and is coming off a day in the red. The US dollar broadly weakened on Thursday as investors wrestle with continued tariff uncertainty. The US dollar index, which measures the dollar's strength against six major foreign currencies, tumbled almost 1% and fell to its lowest level since 2022. This is a developing story and will be updated.
